Arrowhead Pharmaceuticals ARWRNasdaq
88.33USDClose on 08/10
At a glance
Arrowhead Pharmaceuticals sits in the ‘Resting’ stage of its cycle. It has moved +28.0% since its first surge signal on 2025-12-22, when the past-year gain stood at +238.9%.
- Since surge signal
- +28.0%
- First surge signal
- 2025-12-22
- Price at signal
- 69
- Past-year gain (at signal)
- +238.9%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.